Lumiera Health Inc. Stock price

Equities

NHP

CA5502541066

Pharmaceuticals

Delayed Toronto S.E. 09:30:00 2022-12-08 am EST 5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Lumiera Health Inc. -.--% -.--%
Sales 2021 538K 397K Sales 2022 631K 465K Capitalization 850K 627K
Net income 2021 -1M -738K Net income 2022 -2M -1.48M EV / Sales 2021 5.51 x
Net Debt 2021 416K 307K Net Debt 2022 1.88M 1.39M EV / Sales 2022 4.33 x
P/E ratio 2021
-1.52 x
P/E ratio 2022
-0.31 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 62.87%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.01
Extreme 0.005
0.06
5 years
0.01
Extreme 0.005
0.28
10 years
0.01
Extreme 0.005
0.43
More quotes
Managers TitleAgeSince
Director of Finance/CFO 66 21-11-17
Members of the board TitleAgeSince
Chairman - 20-08-31
Director/Board Member - 22-02-21
Director of Finance/CFO 66 21-11-17
More insiders
Lumiera Health Inc. is a Canada-based natural health products company. The principal business of the Company is that of selling natural and homeopathic products. The Company specializes in the development and commercialization of evidence-based botanical products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. It is also developing and commercializing a portfolio of innovative solutions in high growth categories such as sleep-aids and pain management. Its product's portfolio categories such as topical pain relief, sleep, skin care, women's health, & infections. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The Holizen portfolio has over 20 products that cover a range of therapeutic needs, including cardiovascular health; stress relief; bones, joints & muscle mobility; energy and immunity.
More about the company
  1. Stock
  2. Equities
  3. Stock Lumiera Health Inc. - Toronto S.E.